Welcome to the European Association for Cancer Research
Connecting cancer researchers together
EACR-AstraZeneca Conference: Circulating Nucleic Acids (cfDNA/ctDNA): In use, in view and on the horizon
Virtual Event, Worldwide : 28 - 29 January 2025
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Opening words: James Hadfield
Session 1: Horizons for Liquid Biopsy
Session Chair: James Hadfield
KEYNOTE LECTURE
Yuval Dor Hebrew University of Jerusalem, Jerusalem, Israel
'Epigenetic liquid biopsy'
Q&A 13:25-13:40
Viktor Adalsteinsson Gerstner Centre for Cancer Diagnostics, Broad Institute, Cambridge, USA
'Modulating cfDNA biology to enhance liquid biopsies'
Q&A 14:00-14:15
Davina Gale AstraZeneca, Cambridge, UK
'Pathway to cure: application of ctDNA in clinical trials'
Q&A 14:35-14:50
REFRESHMENT BREAK
Session 2: Liquid biopsies for breast and lung cancers
Session Chairs: Davina Gale and James Hadfield
Heather Parsons Dana-Farber Cancer Institute, Boston, USA
'How low should we go? ctDNA to detect MRD in breast cancer'
Q&A 15:25-15:40
Andreas Risch MGZ Munich, Munich, Germany
Proffered Paper 1: 'Liquid biopsy analysis of advanced breast cancer patients – A real-life perspective of actionable variants'
Q&A 15:50-15:55
Albert Grinshpun Shaare Zedek Medical Center, Jerusalem, Israel
Proffered Paper 2: 'Utilization of cfDNA in Detecting Drug-Induced Lung Toxicity'
Q&A 16:05 - 16:10
Max Diehn Stanford University School of Medicine, Stanford, USA
'Liquid biopsies for detection and characterization of lung cancers'
Q&A 16:30-16:45
SPOTLIGHT PRESENTATIONS
3 five minute Spotlight talks, from high-scoring abstracts submitted to the meeting.
FLASH TALKS - Session 1
A selection of short 3-minute flash talks from selected abstracts submitted to the meeting.
END OF DAY 1
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
Session 3: Liquid biopsy in colorectal and bladder cancers
Session Chair: Evi Lianidou
Naureen Starling The Royal Marsden NHS Foundation Trust, London, UK
'Circulating nucleic acids (cfDNA/ctDNA): in use, in view and on the horizon’ a GI perspective but with broader applicability'
Q&A 14:25-14:40
Silvia Marsoni IFOM, Milan, Italy
'Leveraging liquid biopsy to deconvolute colon cancer biology'
Q&A 15:00-15:15
Lars Dyrskjøt Aarhus University. Aarhus, Denmark
'Towards ctDNA-guided treatment of muscle-invasive bladder cancer'
Q&A 15:35-15:50
REFRESHMENT BREAK
Session 4: Next generation liquid biopsy researchers
Session Chair: Caroline Dive
Daniel Hagey Karolinska Institutet, Stockholm, Sweden
Proffered Paper 3: 'Dynamic size and association profiles of tumour-derived DNA during pancreatic cancer progression'
Q&A 16:15-16:20
Lucy Faulkner University of Cambridge, Cambridge, UK
Proffered Paper 4: 'Assessing response to androgen deprivation and surgery using methylation sequencing of ctDNA from plasma and urine in localised prostate cancer'
Q&A 16:30-16:35
FLASH TALKS - Session 2
A selection of short 3-minute flash talks from selected abstracts submitted to the meeting.
KEYNOTE LECTURE
Victor Velculescu Johns Hopkins University School of Medicine, Baltimore, USA
'Early Detection of Cancer using cell-free DNA Fragmentomes'
Q&A 17:10-17:25
DISCUSSION SESSION
Clinical implementation and new technologies
Silvia Marsoni (Chair), IFOM, Milan, Italy; Caroline Dive, CRUK Manchester, UK; James Hadfield, AstraZeneca, Cambridge, UK; Davina Gale, AstraZeneca, Cambridge, UK
SUMMARY AND CLOSE
